Syntheses, Biological Activity, and Conformational Analysis of Fluorine-Containing Taxoids

ACS Symposium Series

Volumn 639, Issue , 1996, Pages 228-243

  Ojima, Iwao ^a   Kuduk, Scott D ^a   Slater, John C ^a   Gimi, Rayomand H ^a   Sun, Chung Ming ^a   Chakravarty, Subrata ^a   Ourevitch, Michele ^b   Abouabdellah, Ahmed ^b   Bonnet Delpon, Danièle ^b   Bégué, Jean Pierre ^b   Veith, Jean M ^c   Pera, Paula ^c   Bernacki, Ralph J ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012077542     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (63)

1. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Ed.; American Chemical Society: Washington D.C., 1995
2. Suffness, M. In Annual Reports in Medicinal Chemistry; J. A. Bristol, Ed.; Academic Press: San Diego, 1993; Vol. 28; Chapter 32, pp 305-314.
3. Suffness, M. Taxol: Science and Applications; CRC Press: New York, 1995.
4. Guénard, D.; Guéritte-Vogelein, F.; Potier, P., Acc. Chem. Res. 1993, 26, 160-167.
5. Ravdin, P. M. In Stony Brook Symposium on Taxol and Taxotère; Stony Brook, NY May 14-15, 1993; pp Abstracts p. 18.
6. Verweij, J.; Clavel, M.; Chevalier, B., Ann. Oncol. 1994, 5, 495-505.
7. Ojima, I.; Duclos, O.; Kuduk, S. D.; Sun, C-M.; Slater, J. C.; Lavelle, F.; Veith, J. M.; Bernacki, R. J., BioMed. Chem. Lett. 1994, 4, 2631.
8. Ojima, I.; Park, Y. H.; Sun, C.-M.; Fenoglio, I.; Appendino, G.; Pera, P.; Bernacki, R. J., J. Med. Chem. 1994, 37, 1408.
9. Ojima, I.; Fenoglio, I.; Park, Y. H.; Pera, P.; Bernaki, R. J., BioMed. Chem. Lett. 1994, 4, 1571-1576.
10. Ojima, I.; Fenoglio, I.; Park, Y. H.; Sun, C.-M.; Appendino, G.; Pera, P.; Bernacki, R. J., J. Org. Chem. 1994, 59, 515-517.
11. Ojima, I.; Duclos, O.; Zucco, M.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F., J. Med. Chem. 1994, 37, 2602-2608.
12. Ojima, I.; Park, Y. H.; Fenoglio, I.; Duclos, O.; Sun, C.-M.; Kuduk, S. D.; Zucco, M.; Appendino, G.; Pera, P.; Veith, J. M.; Bernacki, R. J.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F. In Taxane Anticancer Agents: Basic Science and Current Status; G. I. Georg; T. T. Chen; I. Ojima and D. M. Vyas, Ed.; ACS Symp. Series 583; American Chemical Society: Washington, D. C., 1995; pp 262-275.
13. Georg, G. I., 3′-N-(4-Azido-2,3,5,6-tetrafluorobenzoyl)paclitaxel and 7-(4-Azido-2,3,5,6-tetrafluorobenzoyl)paclitaxel have been synthesized as potential photoaffinity labels. See Ref. 14.
14. Georg, G. I.; Harriman, G. C. B.; Park, H.; Himes, R. H., BioMed. Chem. Lett. 1994, 4, 487-490.
15. Chen, S.-H., For the incorporation of fluorine to the baccatin moiety, see Refs. 16 and 17.
16. Chen, S. H.; Kant, J.; Mamber, S. W.; Roth, G. P.; Wei, J.; Marshall, D.; Vyas, D.; Farina, V., BioMed. Chem. Lett. 1994, 4, 2223-2228.
17. Chen, S. H.; Farina, V. In Taxane Anticancer Agents: Basic Science and Current Status; G. I. Georg; T. T. Chen; I. Ojima and D. M. Vyas, Ed.; ACS Symp. Series 583; American Chemical Society: Washington D.C., 1995; pp 247-261.
18. Vander Velde, D. G.; Georg, G. I.; Grunewald, G. L.; Gunn, C. W.; Mitscher, L. A., J. Am. Chem. Soc. 1993, 115, 11650-11651.
19. Georg, G. I.; Harriman, G. C. B.; Vander Velde, D. G.; Boge, T. C.; Cheruvallath, Z. S.; Datta, A.; Hepperle, M.; Park, H.; Himes, R. H.; Jayasinghe, L. In Taxane Anticancer Agents: Basic Science and Current Status; G. I. Georg; T. T. Chen; I. Ojima and D. M. Vyas, Ed.; ACS Symp. Series 583;American Chemical Society: Washington D.C., 1995; pp 217-232.
20. Vuilhorgne, M.; Gaillard, C.; Sanderlink, G. J.; Royer, I.; Monsarrat, B.; Dubois, J.; Wright, M. In Taxane Anticancer Agents: Basic Science and Current Status, G. I. Georg; T. T. Chen; I. Ojima and D. M. Vyas, Ed.; ACS Symp. Series 583; American Chemical Society: Washington D. C., 1995; pp 98-110.
21. Monsarrat, B.; Mariel, E.; Cros, S.; Garés, M.; Guénard, D.; Guéritte-Voegelein, F.; Wright, M., Drug Metab. Dispos. 1990, 18, 895.
22. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications; Filler, R.; Kobayashi, Y.; Yagupolskii, L. M., Ed.; Elsevier: Amsterdam, 1993; Vol. 48.
23. Kukhar, V. P.; Soloshonok, V. A. Fluorine-containing Amino Acids: Synthesis and Properties; John Wiley & Sons: Chichester, 1995.
24. Ojima, I.; Kuduk, S. D.; Slater, J. C.; Gimi, R. H.; Sun, C. M., Tetrahedron 1996, 52, 209-224.
25. 50(paclitaxel) = 1.2.
26. Georg, G. I.; Cheruvallath, Z. S.; Harriman, G. C. B.; Hepperle, M.; Park, H.; Himes, R. H., BioMed. Chem. Lett. 1994, 4, 2331.
27. 50(docetaxel) = 1.49; %T/C = 6; log cell kill 3.2) (see Ref. 28).
28. Commerçon, A.; Bourzat, J. D.; Didier, E.; Lavelle, F. In Taxane Anticancer Agents: Basic Science and Current Status; G. I. Georg; T. T. Chan; I. Ojima and D. M. Vyas, Ed.; American Chemical Society: Washington, D. C., 1995; pp 233-246.
29. Commerçon, A.; Bezard, D.; Bernard, F.; Bourzat, J. D., Tetrahedron Lett. 1992, 33, 5185-5188.
30. Ojima, I. In Advances in Asymmetric Synthesis; A. Hassner, Ed.; JAI Press: Greenwich, 1995; Vol. 1; pp 95-146.
31. Ojima, I. In The Organic Chemistry of β-Lactam Antiobiotics; G. I. Georg, Ed.; VCH Publishers: New York, 1992; pp 197-255.
32. Ojima, I., Acc. Chem. Res. 1995, 28, 383-389.
33. Holton, R. A.; Biediger, R. J.; Boatman, P. D. In Taxol®: Science and Applications; M. Suffness, Ed.; CRC Press: New York, 1995; pp 97-121.
34. Georg, G. I.; Cheruvallath, Z. S.; Himes, R. H.; Mejillano, M. R.; Burke, C. T., J. Med. Chem. 1992, 35, 4230-4237.
35. Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.; Sun, C. M.; Brigaud, T., Tetrahedron 1992, 48, 6985-7012.
36. Ojima, I.; Sun, C. M.; Zucco, M.; Park, Y. H.; Duclos, O.; Kuduk, S. D., Tetrahedron Lett. 1993, 34, 4149-4152.
37. Ojima, I.; Zucco, M.; Duclos, O.; Kuduk, S. D.; Sun, C. M.; Park, Y. H., BioMed Chem. Lett. 1993, 3, 2479-2482.
38. Ojima, I.; Habus, I.; Zhao, M.; Georg, G. I.; Jayasinghe, R., J. Org. Chem. 1991, 56, 1681-1684.
39. Appendino, G.; Gariboldi, P.; Gabetta, B.; Pace, R.; Bombardelli, E.; Viterbo, D., J. Chem. Soc., Perkins Trans 1 1992, 2925-2929.
40. Holton, R. A.; Biediger, R. J., U.S. Patent 1993, 5,243,045.
41. Skehan, P.; Streng, R.; Scudierok, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R., J. Nat. Cancer Inst. 1990, 82, 1107-1112.
42. Ali, S. M.; Hoemann, M. Z.; Aube, J.; Mitscher, L. A.; Georg, G. I.; McCall, R.; Jayasinghe, L. R., J. Med. Chem. 1995, 38, 3821-3828.
43. Rao, S.; Horwitz, S. B.; Ringel, I., J. Natl. Cancer Inst. 1992, 84, 785-788.
44. Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, I.; Orr, G. A.; Horwitz, S. B., J. Biol. Chem. 1994, 269, 3132-3134.
45. Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H., J. Med. Chem. 1994, 37, 2976-2980.
46. Ojima, I.; Duclos, O.; Dormán, G.; Simonot, B.; Prestwich, G. D.; Rao, S.; Lerro, K. A.; Horwitz, S. B., J. Med. Chem. 1995, 38, 3891-3894.
47. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Franci, M. M.; Heerding, J. M.; Krauss, N. E., Can. J. Chem. 1994, 252-260.
48. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Francl, M. M.; Heerding, J. M.; Krauss, N. E., Tetrahedron 1993, 49, 6545-6560.
49. Dubois, J.; Guénard, D.; Guéritte-Voegelein, F.; Guedira, N.; Potier, P.; Gillet, B.; Beloeil, J.-C., Tetrahedron 1993, 49, 6533-6544.
50. Boge, T. C.; Himes, R. H.; Vander Velde, D. G.; Georg, G. I., J. Med. Chem. 1994, 37, 3337-3343.
51. Chmurny, G. N.; Hilton, B. D.; Brobst, S.; Look, S. A.; Witherup, K. M.; Beutler, J. A., J. Nat. Prod. 1992, 54, 416-423.
52. Hilton, B. D.; Chmurny, G. N.; Muschik, G. M., J. Nat. Prod. 1992, 55, 1157-1161.
53. Baker, J. K., Spectroscopy Lett. 1992, 25, 31-48.
54. Falzone, C. J.; Benesi, A. J.; Lecomte, J. T., Tetrahedron Lett. 1992, 33, 1169-1172.
55. Guéritte-Voegelein, F.; Mangatal, L.; Guénard, D.; Potier, P.; Guilhem, J.; Cesario, M.; Pascard, C., Acta Crstallogr. 1990, C46, 781-784.
56. Mastropaolo, D.; Camerman, A.; Luo, Y.; Brayer, G. D.; Camerman, N., Proc. Natl. Acad. Sci. USA 1995, 92, 6920-6924.
57. Georg, G. I., For a comprehensive review on the conformational studies on paclitaxel and docetaxel, see Ref. 58.
58. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol®: Science and Applications; M. Suffness, Ed.; CRC Press: New York, 1995; pp 317-375.
59. Cachau, R. E.; Gussio, R.; Beutler, J. A.; Chmurny, G. N.; Hilton, B. D.; Muschik, G. M.; Erickson, J. W., Int. J. Supercomput. Appl. 1994, 8, 24-34.
60. Wiley, R. A.; Rich, D. H.; Med. Res. Rev. 1993, 3, 327-384.
61. 2O (3:1) could be perfomed at -20 °C (see Ref. 18), but we did not have any luck in keeping the solution from freezing below 0 °C although we were able to obtain clean NMR spectra in glassy state at -20 °C.
62. Paloma, L. G.; Guy, R. K.; Wrasidlo, W.; Nicolaou, K. C., Chem. Biol. 1994, 2, 107-112.
63. Ojima, I.; Kuduk, S. D.; Chakravarty, S.; Ourevitch, M., Unpublished results.